ArticleAnnals of the rheumatic diseases2020

Response to: 'Risk of severe infection following rituximab and the efficacy of antimicrobial prophylaxis' by Wallace

Andreas Kronbichler et al.PubMed ↗Publisher ↗

No numbers read from the abstract.